Platelet-rich plasma, autologous serum, and cyclosporine A improve Sjögren's dry eye outcomes
Comparative efficacy and safety of topical therapies for ocular involvement in Sjögren's syndrome: a systematic review and network meta-analysis.
Abstract
Platelet-rich plasma, autologous serum, and cyclosporine A topical therapies show outcome-specific benefits for Sjögren's dry eye, improving ocular staining, tear stability, and secretion.
